Melanoma
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few...
| Други автори: | Sharfman, William. |
|---|---|
| Формат: | Електронен |
| Език: | English |
| Публикувано: |
New York :
Demos Medical Pub.,
℗♭2012.
|
| Серия: |
Emerging cancer therapeutics ;
v. 3, issue 3. |
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=529438 |
| Подобни документи: |
Print version::
Melanoma. |
| Резюме: |
This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few years ago. Especially significant are the recent FDA approval of the immunotherapeutic agent ipilimumab for metastatic melanoma, and new agents targeting the BRAF gene in malignant melanoma. There is also coverage of the most recent data pertaining to surgical management, staging and prevention, an. |
|---|---|
| Физически характеристики: |
1 online resource (xv, [391]-609 pages :) : illustrations (some color). |
| Библиография: |
Includes bibliographical references and index. |
| ISBN: |
9781617051616 1617051616 |
| ISSN: |
2151-4194 ; |